Amgen Newsroom

Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380

Futu News49minutes ago

Jefferies Remains a Buy on Amgen (AMGN)

TipRanks04:37

Amgen Analyst Ratings

BenzingaOct 14 21:57

Truist Financial Downgrades Amgen(AMGN.US) to Hold Rating, Announces Target Price $333

Futu NewsOct 14 18:34

Morgan Stanley Adjusts Price Target on Amgen to $319 From $316

MT NewswiresOct 11 21:34

Morgan Stanley Keeps Their Hold Rating on Amgen (AMGN)

TipRanksOct 11 20:39

Amgen Analyst Ratings

BenzingaOct 8 02:22

Barclays Keeps Their Hold Rating on Amgen (AMGN)

TipRanksOct 7 10:20

Barclays Adjusts Price Target on Amgen to $315 From $300, Maintains Equalweight Rating

MT NewswiresOct 4 19:09

DBS Maintains Amgen(AMGN.US) With Buy Rating

Futu NewsOct 4 17:31

Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380

Futu NewsOct 3 20:31

Amgen Analyst Ratings

BenzingaSep 28 01:13

Cantor Fitzgerald Initiates Amgen(AMGN.US) With Buy Rating, Announces Target Price $405

Futu NewsSep 27 20:31

RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $362

Futu NewsSep 26 19:31

RBC Capital Sticks to Its Buy Rating for Amgen (AMGN)

TipRanksSep 26 19:07

Amgen Analyst Ratings

BenzingaSep 25 23:00

Baird Reiterates Underperform on Amgen, Maintains $215 Price Target

BenzingaSep 25 23:00

Baird Maintains Amgen(AMGN.US) With Sell Rating, Maintains Target Price $215

Futu NewsSep 25 22:31

Leerink Partners Maintains Amgen(AMGN.US) With Hold Rating

Futu NewsSep 25 22:31

Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380

Futu NewsSep 25 21:32